SCHEMBL31128564

SCHEMBL31128564

CCc1ncc(CC)c(=O)[nH]1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS2 Q9H2K2 1/20 0.42
GRIN2D O15399 2/20 0.40
GRIN3B O60391 2/20 0.40
GRIN1 Q05586 2/20 0.40
GRIN2A Q12879 2/20 0.40
GRIN2B Q13224 2/20 0.40
GRIN2C Q14957 2/20 0.40
GRIN3A Q8TCU5 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
TP53 P04637 1/20 0.39
NPC1 O15118 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
NOS3 P29474 1/20 0.35
NOS1 P29475 1/20 0.35
NOS2 P35228 1/20 0.35
GCK P35557 1/20 0.35
ALDH1A1 P00352 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23987019 0.81 ALDH1A1 (0.55) TNKS2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL38666295 0.79 DAO (0.41) TNKS2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL19049572 0.79 DAO (0.56) TNKS2DAO
SCHEMBL23986978 0.79 TNKS2 (0.40) TNKS2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL25598726 0.78 HRH1 (0.41) TNKS2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL23987122 0.78 HCAR2 (0.37) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL13039021 0.77 NOS1 (0.42) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL26018563 0.77 GRIN2D (0.39) TNKS2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL3394187 0.77 GRIN2D (0.41) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL23222270 0.76 KDM4E (0.51) TNKS2GRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024173343-A1 COMPOUNDS TARGETING HYDROXYSTEROID 17-BETA DEHYDROGENASE (HSD17B) AND USES THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2024-08-22 WO disclosed